Medtech has already seen a strong showing of M&A activity this month, starting with Stryker announcing its intention to buy Inari Medical in a deal valued at $4.9 billion. Next came Boston Scientific pulling the trigger on Bolt Medical, a company it had invested in since 2019. Is it too soon to get our hopes up for more to come on the medtech M&A front in 2025? Medical Device and Diagnostic Industry (MD+DI) combed through presentations from the J.P. Morgan Healthcare Conference that wrapped up last week, along with recent earnings reports, to find out which medtech companies are hungry for M&A this year and which companies are likely to be a bit more picky with their capital allocations.
Read the full article: Measuring Medtech’s M&A Appetite in 2025 //
Source: https://www.mddionline.com/ma/measuring-medtech-s-m-a-appetite-in-2025